Early and Consistent Improvements in Urinary Symptoms and Quality of Life With OnabotulinumtoxinA in Patients With Overactive Bladder and Urinary Incontinence: Results From a Randomized, Placebo-controlled, Phase IV Clinical Trial

This randomized, multicenter, placebo-controlled, phase IV study assessed the efficacy and tolerability of onabotulinumtoxinA in patients with overactive bladder. METHODS: Patients were randomized 1:1 to onabotulinumtoxinA 100 U or placebo. Assessments over 12 weeks included: change from baseline in...

Descripción completa

Detalles Bibliográficos
Autores principales: McCammon, Kurt, Gousse, Angelo, Kohan, Alfred, Glazier, David, Gruenenfelder, Jennifer, Bai, Zhanying, Patel, Anand, Hale, Douglass
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238435/
https://www.ncbi.nlm.nih.gov/pubmed/32665528
http://dx.doi.org/10.1097/SPV.0000000000000914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238435/
https://www.ncbi.nlm.nih.gov/pubmed/32665528
http://dx.doi.org/10.1097/SPV.0000000000000914

Ejemplares similares